Atlas Trials

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Clinical trial NCT07754461 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07754461
Sponsor
Boehringer Ingelheim
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2026-08-24
Primary completion
2028-01-17
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.